The 340B drug pricing program is vital to many covered entities and, by extension, to the patients that those entities serve.
On the recordOctober 10, 2017
Source
congress.govEditor's note · Context
Griffith emphasizes the importance of the 340B program for healthcare entities and their patients.
Share
More from Howard Griffith
Apr 30, 2025
I am not against States' rights. I am against creating a super State in California because they are the only ones that are entitled to get a waiver and then claiming, as the Government Accountability Office, that they have some kind of…
Feb 26, 2025
When debating this resolution, H.J. Res. 35, is it appropriate to discuss superfluous matters to the matter at hand currently on the floor? The SPEAKER pro tempore. Under clause 1 of rule XVII, remarks in debate must be confined to the…
Feb 26, 2025
Parliamentary inquiry. The SPEAKER pro tempore. Does the gentleman from New York yield for a parliamentary inquiry?





